Is Beaten-Down Phibro Animal Health Stock a Buy Following an Insider Purchase of 10,000 Shares?

2 hours ago 6

Cory Renauer, The Motley Fool

Sat, June 13, 2026 astatine 11:40 AM CDT 4 min read

E. Thomas Corcoran, Director of Phibro Animal Health Corporation (NASDAQ:PAHC), reported the acquisition of 10,000 shares of Common Stock astatine a weighted mean terms of $31.77 per stock connected May 29, 2026, according to a SEC Form 4 filing.

Transaction summary

Metric

Value

Shares traded

10,000

Transaction value

~$318,000

Post-transaction shares (direct)

41,459

Post-transaction worth (direct ownership)

~$1.27 million

Transaction worth based connected SEC Form 4 weighted mean acquisition terms ($31.77); post-transaction worth based connected May 29, 2026 transaction terms ($31.77).

Key questions

  • How does this transaction comparison to Corcoran's anterior trading activity?
    The 10,000-share acquisition is the largest of 3 open-market acquisitions made by Corcoran since September 2024, exceeding his anterior buys of 5,000 shares each.

  • What is the existent capableness for further acquisitions?
    Following this transaction, Corcoran's holdings accrued by 31.79% to 41,459 shares, providing an enlarged capableness for aboriginal enactment comparative to his anterior baseline.

  • Was this acquisition timed astir worldly changes successful marketplace price?
    The acquisition occurred with shares priced astatine $31.77, intimately aligning with the May 29, 2026, marketplace unfastened of $31.76 and closing astatine $30.66, indicating the acquisition was not timed to a melodramatic terms move.

  • Does the transaction bespeak a alteration successful indirect oregon derivative exposure?
    No indirect oregon derivative transactions were disclosed; Corcoran's full vulnerability remains successful straight held Class A Common Stock.

Company overview

Metric

Value

Revenue (TTM)

$1.50 billion

Net income (TTM)

$95.23 million

Dividend yield

1..5%

1-year terms change

-17.45%

* 1-year terms alteration calculated utilizing June 12, 2026, arsenic the notation date.

Company snapshot

  • Phibro Animal Health Corporation offers a portfolio of carnal wellness products, mineral nutrition solutions, and specialty show products, with gross chiefly generated from income to the livestock industry.

  • The institution operates a vertically integrated concern model, developing, manufacturing, and selling products that code carnal health, illness prevention, and nutritional needs for food-producing animals.

  • Primary customers see integrated poultry, swine, and cattle producers, arsenic good arsenic commercialized provender manufacturers, wholesalers, and distributors crossed the United States and planetary markets.

Phibro Animal Health Corporation is simply a starring supplier of carnal wellness and mineral nutrition products, serving a planetary lawsuit basal with a absorption connected nutrient carnal production. The institution leverages a diversified merchandise portfolio and established organisation channels to support a competitory presumption successful the carnal wellness industry.

Read Entire Article